(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one Struktur
1839099-22-7
CAS-Nr.
1839099-22-7
Englisch Name:
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one
Synonyma:
Ilutinib impurity 3;Ibrutinib iMpurity BX;(R)-N-Desacryloyl N-Propionyl Ibrutinib;3-(4-PHENOXYPHENYL)-1-(1-PROPIONYLPIPERIDIN-3-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE;(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone;1-Propanone, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Ibrutinib Impurity);Ibrutinib impurity 7/(R)-N-Desacryloyl N-Propionyl Ibrutinib/1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone
CBNumber:
CB03040890
Summenformel:
C25H26N6O2
Molgewicht:
442.51
MOL-Datei:
1839099-22-7.mol

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one Eigenschaften

Schmelzpunkt:
95-99°C
Siedepunkt:
697.4±55.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
storage temp. 
Refrigerator
Löslichkeit
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka
4.09±0.30(Predicted)
Aggregatzustand
Solid
Farbe
White to Pale Grey

Sicherheit

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(R)-N-Desacryloyl N-Propionyl Ibrutinib is an inhibitor for bruton’s tyrosine kinase.

(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 50)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
info@fdachem.com China 7845 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
AFINE CHEMICALS LIMITED
0571-85134551
info@afinechem.com CHINA 15377 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
ChemShuttle, Inc. 0510-83588313-802 18800520310;
sales@chemshuttle.com China 3009 62
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
sales@bjcomparison.com China 4673 58
ChemStrong Scientific Co.,Ltd 0755-66853366 13670046396
sales@chem-strong.com China 17982 56

1839099-22-7()Verwandte Suche:


  • (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone
  • Ibrutinib impurity 7/(R)-N-Desacryloyl N-Propionyl Ibrutinib/1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone
  • (R)-N-Desacryloyl N-Propionyl Ibrutinib
  • 1-Propanone, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
  • Ibrutinib iMpurity BX
  • 3-(4-PHENOXYPHENYL)-1-(1-PROPIONYLPIPERIDIN-3-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
  • (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Ibrutinib Impurity)
  • Ilutinib impurity 3
  • 1839099-22-7
Copyright 2019 © ChemicalBook. All rights reserved